Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

    BMJ Open Date published:

  • Outcomes of Corynebacterium Peritonitis: A Multicenter Registry Analysis

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study

    Nephrology Date published:

  • Long-term allograft and patient outcomes of kidney transplant recipients with and without incident cancer - a population cohort study

    Oncotarget Date published:

  • Representativeness of Honeypot Trial Participants to Australasian PD Patients

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Breast Cancer and Transplantation

    American Journal of Transplantation Date published:

  • Association of Socio-Economic Position with Technique Failure and Mortality in Australian Non-Indigenous Peritoneal Dialysis Patients

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Multicenter Registry Analysis of Center Characteristics Associated with Technique Failure in Patients on Incident Peritoneal Dialysis

    Clinical Journal of the American Society of Nephrology Date published:

  • Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial

    Nephrology Date published:

  • SP427GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS

    Nephrology Dialysis Transplantation Date published:

  • SP493EARLY PERITONITIS AND ITS OUTCOME IN INCIDENT PERITONEAL DIALYSIS PATIENTS

    Nephrology Dialysis Transplantation Date published:

  • Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients

    Cochrane Database of Systematic Reviews Date published:

  • Effect of Fish Oil Supplementation and Aspirin Use on Arteriovenous Fistula Failure in Patients Requiring Hemodialysis

    JAMA Internal Medicine Date published:

  • GLUCOSE-LOWERING DRUGS ADDED TO EXISTING THERAPIES AND RISKS OF MORTALITY AND CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES: NETWORK META-ANALYSIS OF RANDOMIZED TRIALS

    Date published:

  • Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial

    Kidney and Blood Pressure Research Date published: